宫性 dystonia 的认知障碍:与非运动症状相关的核心临床特征或二次效应?
Małgorzata Dudzic1, Anna Pieczyńska2, Artur Drużdż3
1Department of Neurology, Municipal Hospital in Poznan, Poland. gosiadudzic@gmail.com.
认知障碍在宫性 dystonia (CD) 中很常见,超过一半的患者受到影响. 睡眠障碍显著预测CD患者的认知衰退,突出症状的复杂相互作用.
科学领域:
- 神经学 神经学
- 神经心理学 神经心理学
背景情况:
- 认知障碍是宫性 dystonia (CD) 的一个普遍的非运动症状.
- 在CD中,认知功能障碍,运动症状和其他非运动症状之间的关系尚不清楚.
研究的目的:
- 为了研究CD患者的认知功能障碍.
- 为了确定认知障碍是独立的特征还是与其他症状相关的.
主要方法:
- 评估了34名CD患者和33名对照组.
- 在CD患者的肉毒素 (BoNT) 治疗前后评估认知功能,情绪和睡眠.
主要成果:
- 52.9%的CD患者表现出认知障碍 (相对于3%的对照组).
- 慢性病患者在执行功能,视觉空间能力,语言,记忆和注意力方面表现出缺陷.
- 博恩特治疗改善了认知得分,特别是在执行功能,视觉空间能力,语言和记忆方面.
- 睡眠障碍是认知功能最强的负面预测因素;高等教育具有保护作用.
结论:
- 认知障碍在CD中很常见,并且可以通过治疗改善.
- 睡眠障碍显著影响CD患者的认知功能.
- 这些发现表明CD中运动和非运动症状之间的复杂相互作用,而不是认知障碍仅仅是核心特征.
更多相关视频
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
相关概念视频
Parkinson's Disease: Overview
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
